Castellum, Inc. Director Granted 100,000 Stock Options as Compensation
Castellum, Inc.
Subscribe to track CTM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Castellum Director Receives Stock Option Grant
Company: Castellum, Inc. (CTM) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: McMillen Charles Thomas Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 100,000 (Stock Options) • Price: $0.00 • Value: $0 • Owned After: 100,000 options
Key Insight: A director was granted 100,000 stock options as compensation. This represents a potential 0.11% dilution to shares outstanding, which is a routine corporate governance event.
Market Context: The grant aligns the director's interests with shareholders of the $110M market cap company. The options have an exercise price of $1.19 and vest over 20 months.
Comprehensive Analysis
SEC Filing Analysis: Castellum, Inc. (CTM)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine grant of 100,000 stock options as part of their compensation package.
- Market Impact: Neutral. This is a standard corporate governance action and not an open-market transaction, indicating no new insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Castellum, Inc. |
| Ticker Symbol | CTM |
| CIK | 0001877939 |
| Industry | SERVICES-MANAGEMENT CONSULTING SERVICES |
Insider Information
| Field | Value |
|---|---|
| Name | McMillen Charles Thomas |
| CIK | 0001332108 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-11 |
| Transaction Code | A (Award) |
| Security Type | Stock Options |
| Shares Involved | 100,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 100,000 (options) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 100,000 (options) |
| % of Shares Outstanding | 0.11% |
| Post-Transaction Ownership | 100,000 options (potential 0.11% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For Castellum, a small-cap company with a $110 million market capitalization, this grant is a standard method to provide equity-based compensation without a significant cash outlay.
- Ownership Concentration: This grant establishes a small potential ownership stake for the director, intended to align his interests with those of shareholders.
- Dilution Impact: The potential exercise of these 100,000 options would result in a dilution of approximately 0.11% to the 93,000,584 shares outstanding. This is a minimal level of dilution and is not material to existing shareholders.
- Transaction Significance: The transaction's significance is low. It is a non-cash award for services, not an open-market purchase reflecting new insider confidence. The size relative to shares outstanding is below any significant threshold.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a pre-planned compensation grant, not a discretionary open-market trade. It does not signal a change in the insider's view of the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: Negligible. As this is not a market transaction, it will not directly impact trading volume.
- Sentiment Indicator: Neutral. The market generally views such compensation grants as routine business.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnote clarifies this is a grant for service as an independent director. The options have an exercise price of $1.19 and vest ratably over twenty months starting December 1, 2025.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
